T-CYPHER BIO LIMITED - Profile & Financials

Accounts Submitted 3 Sept 2025

Confirmation Statement Submitted 29 Oct 2025

Net assets £-9.81M £4.38M 2023 year on year

Total assets £8.19M £4.98M 2023 year on year

Total Liabilities £17.68M £9.04M 2023 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

3rd Floor, The Sherard Building 3rd Floor, The Sherard Building Edmund Halley Road, Oxford Science Park Oxford OX4 4DQ United Kingdom

Office ()

Oxford, Oxfordshire, United Kingdom, Europe

Website

tcypherbio.com

Credit Report

Discover T-CYPHER BIO LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2016–2023)

Cash in Bank

£5.86M

Increased by £4.57M (+354%)

Net Assets

-£9.81M

Decreased by £4.38M (-81%)

Total Liabilities

£17.68M

Increased by £9.04M (+105%)

Turnover

N/A

Employees

Increased by 2 (+10%)

Debt Ratio

216%

Decreased by 53 (-20%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

£539k awarded

Show:

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

22 Allotments 8,072,071 Shares £4.78m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
20 Oct 2020	B ORDINARY	1	£1.54m	£1.54m
19 Oct 2020	A ORDINARY	767,775	£4k	£0.005
19 Oct 2020	B ORDINARY	767,775	£4k	£0.005
6 May 2020	ORDINARY	143,590	£1k	£0.01
6 May 2020	ORDINARY	10,000	£100	£0.01

Officers

4 active 11 resigned

Show resigned officers

						Status
Claire Brown	Director	British	England	54	25 Aug 2021	Active
Owen Hughes	Director	American	United States	51	1 Nov 2024	Active
Shyam Masrani	Director	British	England	36	29 Jun 2023	Active
Thomas Lars Andresen	Director	Danish	Denmark	53	2 Aug 2021	Active

Shareholders

Shareholders (20)


Wcs Nominees Ltd	0.0%	Ordinary	27 Nov 2020
Vox Health Fund, Lp	0.0%	Ordinary	27 Nov 2020
Tt Nominees Limited	0.0%	Ordinary	27 Nov 2020

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

T Cypher Bio Holdings Ltd

United Kingdom

Active

Notified 18 Nov 2020

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

Oxford Sciences Innovation Plc

Ceased 18 Nov 2020

Ceased

See All Controllers

Group Structure

T-CYPHER BIO HOLDINGS LIMITED united kingdom shares 50 to 75 percent, voting rights 50 to 75 percent, appoint/remove directors

OXFORD SCIENCE ENTERPRISES PLC united kingdom

T-CYPHER BIO LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
29 Oct 2025	Confirmation Statement	Confirmation statement made on 2025-10-26 with no updates	View(3 pages)
3 Sept 2025	Accounts	Annual accounts made up to 2024-12-31	View(14 pages)
8 Nov 2024	Officers	Appointment of Mr Owen Hughes as director on 2024-11-01	View(2 pages)
31 Oct 2024	Confirmation Statement	Confirmation statement made on 2024-10-26 with no updates	View(3 pages)
25 Jul 2024	Accounts	Annual accounts made up to 2023-12-31	View(11 pages)